QMA

Blood Collection Device For Cell-Free Nucleic Acid

Product code
QMA
Device name
Blood Collection Device For Cell-Free Nucleic Acid
Device class
Class 2
21 CFR
21 CFR 862.1676
Medical specialty
Clinical Chemistry
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
2 (all years; only the last 3 years are listed here)

FDA classification definition

A blood collection device for cell-free nucleic acids is a device intended for medical purposes to collect, store, transport, and handle blood specimens and to stabilize and isolate cell-free nucleic acid components prior to further testing.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2024-07-26.

NumberDecision dateApplicantDevice nameSummary
K2317762024-07-26Streck, Inc.Cell-Free DNA BCT
Official FDA classification page: QMA
Classification and pathway per current FDA publications. Data from openFDA (CC0).